Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Infectious disease and vaccine experts have laid out a plan for thwarting yet another uptick in transmission and illness. A new surge is likely by the end of April, they say in a CIDRAP report.
The agency has alerted healthcare providers that it is monitoring approved SARS-CoV-2 molecular tests to ensure that new viral mutations do not alter their accuracy.
People who are predisposed to Parkinson’s may tend to avoid drinking coffee. Alternatively, some mutation carriers may drink a lot of coffee and benefit from its neuroprotective effects, propose investigators.
The pandemic may have started as early as October 2019, quickly adapting to its human host, according to a new genetic analysis.
A newer, more contagious coronavirus mutation has become dominant worldwide, according to investigators from Los Alamos National Laboratory.
The U.S. Food and Drug Administration has given premarket approval to the cobas® EGFR Mutation Test from Roche Molecular Systems, creating a possible future option for metastatic lung cancer patients.
